NIFTY PHARMA Sector Analysis (1W TF) - 10th July, 2024
- After the breakout of the box consolidation in beginning of June, 2024
- The entire set of stocks in this sector has been showing continuous strength
- Looks like there is a little more steam for the sector till it hits a pause at the resistance
- Even with todays volatility the stocks showed some good pullbacks towards the end of the day
Stocks in Focus:
- Will be keeping a close eye on SYNGENE & GLAND (on a weekly time frame)
- Going to wait it out for another day for the charts to form to give a sense of clarity
Sector Stocks that have shown continuous strength from beginning of 2024:
- Auropharma, Biocon, Divislab, Glenmark etc
Sector Stocks that have show reversals since June, 2024:
- AbbotIndia, Alkem , Cipla, DrReddy, Gland etc
* Disclaimer
- After the breakout of the box consolidation in beginning of June, 2024
- The entire set of stocks in this sector has been showing continuous strength
- Looks like there is a little more steam for the sector till it hits a pause at the resistance
- Even with todays volatility the stocks showed some good pullbacks towards the end of the day
Stocks in Focus:
- Will be keeping a close eye on SYNGENE & GLAND (on a weekly time frame)
- Going to wait it out for another day for the charts to form to give a sense of clarity
Sector Stocks that have shown continuous strength from beginning of 2024:
- Auropharma, Biocon, Divislab, Glenmark etc
Sector Stocks that have show reversals since June, 2024:
- AbbotIndia, Alkem , Cipla, DrReddy, Gland etc
* Disclaimer
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.